Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate whether percutaneous Patent Foramen Ovale (PFO) closure, using the AMPLATZER PFO Occluder, is superior to current standard of care medical treatment in the ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Abbott Medical Devices
NCT07172464 · PFO, PFO - Patent Foramen Ovale, and more
NCT04075084 · Tachycardia, Atrial Fibrillation, and more
NCT05537753 · Patent Foramen Ovale, Cryptogenic Stroke
NCT05774288 · Patent Foramen Ovale, Cryptogenic Stroke
NCT05529901 · Stroke, PFO - Patent Foramen Ovale, and more
University of Alabama
Birmingham, Alabama
Mayo Clinic
Scottsdale, Arizona
LAC + USC Medical Center
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions